Table 2.
Screening Method | Technique | Advantages | Disadvantages |
---|---|---|---|
Colonoscopy | Involves the insertion of a flexible tube with a camera (colonoscope) into the rectum to examine the entire colon for polyps or cancerous growths. | -Direct visualization allows for the detection and removal of precancerous polyps during the procedure. | -Requires bowel preparation, which may be uncomfortable. -Invasive procedure with a small risk of complications, such as bleeding or perforation. |
Flexible Sigmoidoscopy | Involves the insertion of a thin, flexible tube with a camera (sigmoidoscope) into the rectum and lower part of the colon to examine for polyps or cancerous growths. | -Less invasive than colonoscopy. -Does not require full bowel preparation. |
-Limited in scope compared to colonoscopy; only examines the lower part of the colon. -Polyps or cancers in the upper colon may be missed. -Positive findings require follow-up colonoscopy. |
CT Colonography | Uses CT scans to create detailed images of the colon and rectum, allowing for the detection of polyps or cancerous growths. | -Noninvasive and does not require sedation. -No risk of perforation. -Provides detailed images of the entire colon. |
-Requires bowel preparation similar to colonoscopy. -Polyps found may require follow-up colonoscopy for removal. -Radiation exposure from CT scans. |
Capsule Endoscopy | Capsule endoscopy involves swallowing a small camera that captures images of the colon as it passes through the digestive tract. | -Noninvasive -No need for sedation -Provides comprehensive visualization of the entire GI tract -Better detection of polyps and early cancers |
-Requires bowel preparation -Limited availability and accessibility -Risk of capsule retention -Not therapeutic; positive findings require follow-up colonoscopy -Possible technical issues (e.g., battery life, transmission problems) |
Fecal Immunochemical Test (FIT) | A stool-based test that detects hidden blood in the stool, which can be a sign of colorectal cancer or polyps. | -Noninvasive and simple to perform at home. No dietary or medication restrictions before the test. -No need for bowel preparation. |
-Can produce false-positive results due to bleeding from other sources (e.g., hemorrhoids). -Sensitivity may vary, and polyps or early-stage cancer may not always be detected. -A follow-up colonoscopy is required if the test is positive. |
Stool DNA Test (mt-sDNA) | A stool-based test that combines FIT with analysis of DNA markers associated with colorectal cancer. | -Higher sensitivity for detecting advanced adenomas and colorectal cancer compared to FIT alone. -Noninvasive and can be performed at home without dietary or medication restrictions. |
-More expensive than FIT. -False-positive results can occur, leading to unnecessary follow-up testing. -Requires collection of multiple stool samples. |
gFOBT | gFOBT detects hidden blood in stool samples, suggesting bleeding from polyps or cancer using guaiac-based chemical tests. | -Noninvasive -Easy to perform at home -No need for bowel preparation -Low cost -No sedation needed |
-Lower sensitivity and specificity compared to other methods -High false-positive rate -Requires multiple samples -Dietary restrictions prior to the test -Not diagnostic; positive results need follow-up colonoscopy -Can miss polyps and early cancers |
ACG: American College of Gastroenterology; USMSTF: United State Multi-Society Task Force; ACS: American Cancer Society; USPSTF: United States Preventive Services Task Force; NCCN: National Comprehensive Cancer Network; ACP: American College of Physicians; gFOBT: guaiac fecal occult blood test; FIT: fecal immunohistochemical test; mt-sDNA: Multi-Target Stool DNA.